| 000 | 11357nam a22005293i 4500 | ||
|---|---|---|---|
| 001 | EBC4178311 | ||
| 003 | MiAaPQ | ||
| 005 | 20240729130127.0 | ||
| 006 | m o d | | ||
| 007 | cr cnu|||||||| | ||
| 008 | 240724s2015 xx o ||||0 eng d | ||
| 020 |
_a9783319201856 _q(electronic bk.) |
||
| 020 | _z9783319201849 | ||
| 035 | _a(MiAaPQ)EBC4178311 | ||
| 035 | _a(Au-PeEL)EBL4178311 | ||
| 035 | _a(CaPaEBR)ebr11123125 | ||
| 035 | _a(CaONFJC)MIL838308 | ||
| 035 | _a(OCoLC)922581469 | ||
| 040 |
_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ |
||
| 050 | 4 | _aRG1-991 | |
| 082 | 0 | _a613.9/43 | |
| 100 | 1 | _aShoupe, Donna. | |
| 245 | 1 | 4 |
_aThe Handbook of Contraception : _bA Guide for Practical Management. |
| 250 | _a2nd ed. | ||
| 264 | 1 |
_aCham : _bSpringer International Publishing AG, _c2015. |
|
| 264 | 4 | _c©2016. | |
| 300 | _a1 online resource (300 pages) | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 490 | 1 | _aCurrent Clinical Practice Series | |
| 505 | 0 | _aIntro -- Dedication -- Series Editor Introduction -- Preface -- Contents -- List of Contributors -- Chapter 1: Contraceptive Effectiveness -- Introduction -- What Is Efficacy Verses Effectiveness? -- Measuring Contraceptive Efficacy -- Efficacy of Current Contraceptive Methods -- No Method -- Female Sterilization -- Male Sterilization -- Intrauterine Device (Paragard/Mirena/Skyla/Liletta) -- Etonogestrel Subdermal Implant (Implanon/Nexplanon) -- Depot Medroxyprogesterone Acetate (DepoProvera) -- Contraceptive Pills, Patches, Rings -- Condoms -- Female Barrier Methods (Diaphragm, Cervical Cap, Contraceptive Sponge) -- Spermicides -- Fertility Awareness Methods -- Withdrawal -- Contraceptive Counseling -- Conclusion -- References -- Chapter 2: Choosing the Right Contraceptive -- General Reproductive Age -- Concerns: Cancer Risk -- Contraceptive Options -- Specific Problems: Acne or Androgen Excess -- Specific Problems: Bleeding Problems -- Specific Problems: Compliance -- Specific Problems: Medical Problems -- Contraceptive Options: IUDs -- Contraceptive Options: Subdermal Implant -- Contraceptive Options: Low-Dose Combination Hormonal Methods: COCs, Vaginal Ring, and Patch -- Contraceptive Options: Depo-Provera (DMPA), Depo-subQ, and Progestin-Only Pill/Mini-Pills -- Contraceptive Options: Barrier Methods -- Contraceptive Options: Emergency Contraception -- Contraceptive Options: Natural Family Planning -- Adolescents -- Counseling the Teenager -- Choosing the Correct Contraceptive Method -- Options for Adolescents: Subdermal Progestin Implant -- Options: Intrauterine Device -- Options: Male and Female Condom -- Options: Oral Contraceptives, Patch, or Ring -- Options: Depo-Provera (DMPA) and Depo-subQ Provera 104™ -- Options: Diaphragm and Cervical Caps or Shields -- Options: Emergency Contraception -- Perimenopausal Women -- Concerns: Cancer Risk. | |
| 505 | 8 | _aConcerns: Perimenopausal Bleeding Problems -- Concerns: Perimenopausal Symptoms -- Concerns: Decline of BMD -- Concerns: Cardiovascular Risks -- Concerns: Breast Cancer Risk -- Contraceptive Options -- Contraceptive Options: Sterilization -- Contraceptive Options: Barrier Methods -- Contraceptive Options: IUDs -- Contraceptive Options: Progestin-Only Methods: Depo-Provera (DMPA), Depo-subQ, Mini-Pills, and Implant -- Contraceptive Options: Emergency Contraception -- Contraceptive Options: Natural Family Planning -- Contraceptive Options: Low-Dose Combination Hormonal Methods-OCs and Vaginal Ring -- Patient Screening and Choosing a Combination Hormonal Method for Perimenopausal Women -- Noncontraceptive Benefits of Low-Dose OCs in Perimenopausal Women -- When It Is Safe to Discontinuing OCs or Switch to Hormone Therapy -- Pregnancy and During Lactation -- Timing of Initiation -- Options -- Contraceptive Options: Implant -- Contraceptive Options: IUD -- Contraceptive Options: Barriers -- Contraceptive Options: Tubal Ligation and Fallopian Tube Micro-insert -- References -- Chapter 3: Contraception for Women with Medical Conditions -- Introduction -- Resources -- US Medical Eligibility Criteria for Contraceptive Use (US MEC) -- US Selected Practice Recommendations (SPR) -- Guidelines for Women with Specific Medical Conditions -- Hypertension -- Diabetes -- Lipid Disorders (Hyperlipidemia) -- Obesity -- Headache -- Current or History of Deep Venous Thrombosis (DVT) or Pulmonary Embolism (PE) -- Tobacco Smoking -- HIDS -- Gynecologic Cancers -- Breast Cancer -- Cervical Cancer and Endometrial Cancer -- Ovarian Cancer -- Solid Organ Transplantation -- Conclusions -- References -- Important Resources -- Chapter 4: Combination Oral Contraceptive Pills -- General Overview of Method -- Category Options -- Clinical Effectiveness -- Mechanism of Action. | |
| 505 | 8 | _aEligibility -- Noncontraceptive Health Benefits -- Initiation -- Counseling Tips -- Summary -- References -- Chapter 5: Progestin-Only Oral Contraceptives -- General Overview of the Method -- Category Options -- Picking the Right Candidate -- Good Candidates -- Poor Candidates -- Advantages -- Contraceptive-Linked Benefits -- Non-contraceptive Benefits -- Disadvantages -- Side Effects -- Serious Side Effects -- Warning Signals -- Reproductive Effects -- Drug Interactions -- Precautions/Contraindications [WHO/CDC Recommendations] [1, 10] -- Counseling Tips -- Instructions to Use -- Timing of Initiation -- Managing Side Effects -- Clinical Effectiveness -- Mechanism of Action -- Tips on Cost and Insurance Issues -- References -- Chapter 6: Transdermal Contraceptive Delivery Systems -- General Overview of Method -- Category Options -- Ethinyl Estradiol/Norelgestromin Transdermal System (EE/NGM TDS, Ortho Evra) -- New Options [in Development] -- A New Transdermal Contraceptive Delivery System: Levonorgestrel and Ethinyl Estradiol (Twirla, Agile Therapeutics) -- Gestodene and Ethinyl Estradiol Transdermal System (Bayer Healthcare) -- Transdermal Progestin Delivery Systems for Contraception -- Desogestrel Transdermal System -- AG1000-6.5: Levonorgestrel Transdermal System -- Norethindrone Acetate Transdermal System -- Picking the Right Candidate for a Contraceptive Patch -- Good Candidates -- Poor Candidates -- Advantages -- Contraceptive-Related Benefits for a Transdermal System -- Non-contraceptive-Linked Benefits -- Disadvantages of a Contraceptive Patch -- Side Effects Associated with Transdermal Contraceptive Delivery Systems -- Serious Side Effects Related to a Transdermal Contraceptive Delivery System -- Warning Signals Associated with Serious Adverse Events -- Reproductive Effects -- Drug Interactions -- Contraindications [WHO/CDC Recommendations]. | |
| 505 | 8 | _aAbsolute Contraindications -- Relative Contraindications -- Counseling Tips -- Instructions to Use -- Timing of Initiation -- Managing Side Effects -- Clinical Effectiveness -- Mechanism of Action -- Tips on Cost and Insurance Issues -- References -- Chapter 7: Contraceptive Ring -- Introduction -- Overview of the Method -- Pharmacokinetics -- Mechanism of Action -- Clinical Effectiveness -- Continuation -- Advantages of the Contraceptive Ring -- Disadvantages of the Contraceptive Ring -- Side Effects -- Venous Thromboembolism -- Arterial Thromboembolism -- Weight Gain -- Hyperlipidemia -- Reproductive Effects -- Cancer Risk -- Contraindications -- Drug Interactions -- Counseling and Patient Selection -- Instructions to Use -- Switching from Another Method -- Starting After Pregnancy -- Counseling Tips -- Poor Candidates -- Summary -- References -- Chapter 8: Progestin Injectable Contraceptives -- General Overview of Method -- Category Options -- Picking the Right Candidate -- Advantages -- Special Issues -- Skeletal Health -- Sexually Transmitted Infection Risk -- Cardiovascular Risk -- Cancer Risk -- Contraindications -- Screening Tests -- Repeat Injections -- Managing Side Effects -- Bleeding -- Weight Gain -- Clinical Effectiveness -- Mechanism of Action -- Tips on Cost and Insurance Issues -- References -- Chapter 9: Implantable Contraception -- Introduction -- History of Implantable Contraception -- Candidates for Implantable Contraception -- Women with Chronic Medical Conditions -- Lactating Women -- Adolescents -- Pharmacology -- Mechanism of Action -- Efficacy -- General Population -- Overweight and Obese Women -- Drug Interactions Impacting Efficacy -- Counseling -- Irregular Bleeding -- Management of Irregular Bleeding -- Other Side Effects -- Sexually Transmitted Infections -- Initiation -- Backup Contraception. | |
| 505 | 8 | _aBox 1 How to be reasonably certain that a woman is not pregnant -- Insertion -- Required Equipment for Etonogestrel Implant Insertion -- Positioning the Patient -- Anesthesia -- Insert Implant -- Verify Placement -- Post-insertion Care and Follow-Up -- Complications of Insertion -- Removal -- Procedure -- Difficult Removals -- Imaging Techniques -- Reinsertion -- Jadelle -- Summary -- References -- Chapter 10: Intrauterine Contraception: Comparison of the Copper T Intrauterine Device with the Levonorgestrel Intrauterine Systems -- Category Options -- General Overview of Methods -- Clinical Effectiveness -- Picking the Right Candidate -- Good Candidates for IUC Use -- Especially Good Candidates for copper T IUD -- Especially Good Candidates for LNG-20 IUS -- Special Populations -- Postpartum -- Post-abortion -- Nulliparity -- HIV -- Poor Candidates for IUC Insertion -- Advantages: Contraceptive-Linked Benefits -- IUD as Emergency Contraception -- Non-contraceptive Benefits -- Therapeutic Uses of the LNG-20 -- Heavy Menstrual Bleeding and Bleeding Disorders -- Endometriosis and Pelvic Pain -- Progestin Therapy to Prevent or Treat Endometrial Hyperplasia -- Clinical Concerns -- Fertility Post-IUC -- Ectopic Pregnancy and IUC -- Counseling Tips -- Insertion Tips -- Loading the Device -- Removal Tips -- Managing Side Effects -- Explusion -- Mechanism of Action -- Timing of Initiation -- Tips on Cost and Insurance Issues -- References -- Chapter 11: Barrier Contraceptives -- Summ ary -- Introduction -- Male Condoms -- Efficacy -- Mechanism of Action -- Advantages of Male Condoms -- Disadvantages of Male Condoms -- Special Comments -- Patient Counseling -- Instructions for Correct Condom Use -- Encouraging Developments -- Vaginal Barriers -- Female Condom (FC2) -- Efficacy -- Mechanism of Action -- Advantages of Female Condom (FC2) -- Disadvantages. | |
| 505 | 8 | _aPatient Counseling. | |
| 588 | _aDescription based on publisher supplied metadata and other sources. | ||
| 590 | _aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. | ||
| 650 | 0 | _aInternal medicine. | |
| 655 | 4 | _aElectronic books. | |
| 700 | 1 | _aMishell, Daniel R., Jr. | |
| 776 | 0 | 8 |
_iPrint version: _aShoupe, Donna _tThe Handbook of Contraception _dCham : Springer International Publishing AG,c2015 _z9783319201849 |
| 797 | 2 | _aProQuest (Firm) | |
| 830 | 0 | _aCurrent Clinical Practice Series | |
| 856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/orpp/detail.action?docID=4178311 _zClick to View |
| 999 |
_c102867 _d102867 |
||